MiRus® proudly announces FDA 510(k) clearance for two groundbreaking products: the CYGNUS™ MoRe® Anterior Cervical Plate and the MiRus® 3DR™ Lateral Lumbar Interbody Fusion System, both setting new industry benchmarks as the slimmest plating systems available in the global spine market.

These innovative systems harness the potential of MoRe®, an exclusive molybdenum rhenium superalloy recognized for its remarkable combination of strength, flexibility, durability, and biocompatibility.MoRe® opens the door to designing smaller, more robust implants that minimize disruption to soft tissues, speed up patient recovery, and elevate overall outcomes.

The proprietary molybdenum-rhenium alloy in the Integrated MoRe® lateral plate achieves an incredibly svelte 2mm thickness without compromising performance. The CYGNUS™ MoRe® ACP and the MiRus® 3DR™ Lateral Lumbar Interbody Fusion system with Integrated MoRe® plate fixation represent major advancements in the global spine market. Our dedication to providing surgeons with innovative solutions that enhance patient outcomes shines through in these groundbreaking products.

Source: prnewswire.com